Genetics of nonsyndromic obesity

Current Opinion in Pediatrics

Volumn 25, Issue 6, 2013, Pages 666-673

  Lee, Yung Seng ^a,b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c AGENCY FOR SCIENCE   (Singapore)

Author keywords

adiposity; epigenetics; genetics; obesity

Indexed keywords

AGOUTI RELATED PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; G PROTEIN COUPLED RECEPTOR; HISTONE DEACETYLASE; INTERMEDIN; MELANOCORTIN 3 RECEPTOR; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ARCUATE NUCLEUS; BARIATRIC SURGERY; BIRTH WEIGHT; BLOOD BRAIN BARRIER; BODY COMPOSITION; BODY MASS; CHILDHOOD OBESITY; CORRELATION ANALYSIS; CPG ISLAND; DISEASE PREDISPOSITION; DNA METHYLATION; EFFECT SIZE; ENERGY EXPENDITURE; ENVIRONMENTAL FACTOR; EPIGENETICS; EPISTASIS; EXOME; FAT MASS; FOOD INTAKE; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENE FREQUENCY; GENE INTERACTION; GENE LOCUS; GENE SILENCING; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HISTONE MODIFICATION; HOMEOSTASIS; HUMAN; MORBIDITY; NONALCOHOLIC FATTY LIVER; NUTRITION EDUCATION; OBESITY; PERSONAL EXPERIENCE; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DNA METHYLATION; EPIGENOMICS; FEMALE; FOOD HABITS; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENETIC THERAPY; GENETIC VARIATION; HUMANS; MALE; OBESITY; PHENOTYPE; SEDENTARY LIFESTYLE;

EID: 84888122524     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e3283658fba     Document Type: Review

References (75)

1. French SA, Story M, Jeffery RW. Environmental influences on eating and physical activity. Annu Rev Public Health 2001; 22:309-335.
2. Bell CG, Walley AJ, Froguel P. The genetics of human obesity. Nat Rev Genet.2005,6:221-234.
3. O'Rahilly S, Farooqi IS. Genetics of obesity. Philos Trans R Soc Lond B Biol Sci 2006; 361:1095-1105.
4. Bouchard C. Current understanding of the etiology of obesity: genetic and nongenetic factors. Am J Clin Nutr 1991; 53:1561S-1565S.
5. Allison DB, Faith MS, Nathan JS. Risch's lambda values for human obesity. Int J Obes Relat Metab Disord 1996; 20:990-999.
6. Allison DB, Kaprio J, Korkeila M, et al. The heritability of body mass index among an international sample of monozygotic twins reared apart. Int J Obes Relat Metab Disord 1996; 20:501-506.
7. Stunkard AJ, Foch TT, Hrubec Z. A twin study of human obesity. JAMA 1986;256:51-54.
8. Maes HH, Neale MC, Eaves LJ. Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 1997; 27:325-351.
9. Stunkard AJ, Sorensen TI, Hanis C, et al. An adoption study of human obesity. N Engl J Med 1986; 314:193-198.
10. Tambs K, Moum T, Eaves LJ, et al. Genetic and environmental contributions to the variance of body height in a sample of first and second degree relatives. Am J Phys Anthropol 1992; 88:285-294.
11. Bouchard C, Perusse L, Leblanc C, et al. Inheritance of the amount and distribution of human body fat. Int J Obes 1988; 12:205-215.
12. Vogler GP, Sorensen TI, Stunkard AJ, et al. Influences of genes and shared family environment on adult body mass index assessed in an adoption study by a comprehensive path model. Int J Obes Relat Metab Disord 1995;19:40-45.
13. Bouchard C, Tremblay A, Despres JP, et al. The response to exercise with constant energy intake in identical twins. Obes Res 1994; 2:400-410.
14. Loos RJ, Bouchard C,Obesity: is it a genetic disorder? J Intern Med.2003.254:401-425.
15. Rankinen T, Zuberi A, Chagnon YC, et al,The human obesity gene map.the 2005 update.Obesity (Silver Spring).2006;14:529-644.
16. Oh IS, Shimizu H, Satoh T, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006; 443:709-712.
17. Ramanjaneya M, Chen J, Brown JE, et al. Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology 2010; 151:3169-3180.
18. Stengel A, Goebel M, Wang L, et al. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropinreleasing factor2 receptor. Endocrinology 2009; 150:4911-4919.
19. Shimizu H, Oh IS, Hashimoto K, et al. Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology.2009:150:662-671.
20. Zegers D, Beckers S, Mertens IL, et al. Association between polymorphisms of the nesfatin gene, NUCB2, and obesity in men. Mol Genet Metab 2011;103:282-286.
21. Chen YY, Chan RM, Tan KM, et al. The association of a nucleobindin 2 gene (NUCB2) variant with childhood adiposity. Gene 2013; 516:48-52.
22. Loos RJ. Genetic determinants of common obesity and their value in prediction. Best Pract Res Clin Endocrinol Metab 2012; 26:211-226.
23. Speliotes EK, Willer CJ, Berndt SI, et al. Association analyses of 249 796 individuals reveal 18 new loci associated with body mass index. Nat Genet, 2010.42:937-948.
24. Whitaker RC, Wright JA, Pepe MS, et al. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997;337:869-873.
25. Moleres A, Rendo-Urteaga T, Zulet MA, et al. Obesity susceptibility loci on body mass index and weight loss in Spanish adolescents after a lifestyle intervention. J Pediatr 2012; 161:466-470; e2.
26. Marian AJ. Elements of 'missing heritability'. Curr Opin Cardiol 2012;27:197-201
27. Zuk O, Hechter E, Sunyaev SR, Lander ES. The mystery of missing heritability: genetic interactions create phantom heritability. Proc Natl Acad Sci U S A.2012;109:1193-1198.
28. Bird A. Perceptions of epigenetics. Nature 2007; 447:396-398.
29. Sato F, Tsuchiya S, Meltzer SJ, Shimizu K. MicroRNAs and epigenetics. FEBS J 2011; 278:1598-1609.
30. Gu SG, Pak J, Guang S, et al. Amplification of siRNA in Caenorhabditis elegans generates a transgenerational sequence-targeted histone H3 lysine 9 methylation footprint. Nat Genet 2012; 44:157-164.
31. Heijmans BT, Tobi EW, Stein AD, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A 2008; 105:17046-17049.
32. Hochberg Z, Feil R, Constancia M, et al. Child health, developmental plasticity, and epigenetic programming. Endocr Rev 2011; 32:159-224.
33. Ravelli GP, Stein ZA, Susser MW. Obesity in young men after famine exposure in utero and early infancy. N Engl J Med 1976; 295:349-353.
34. Ravelli AC, van Der Meulen JH, Osmond C, et al. Obesity at the age of 50 y in men and women exposed to famine prenatally. Am J Clin Nutr 1999; 70:811-816.
35. Godfrey KM, Sheppard A, Gluckman PD, et al. Epigenetic gene promoter methylation at birth is associated with child's later adiposity. Diabetes 2011;60:1528-1534
36. Relton CL, Groom A, St Pourcain B, et al. DNA methylation patterns in cord blood DNA and body size in childhood. PloS One 2012; 7:e31821.
37. Moleres A, Campion J, Milagro FI, et al. Differential DNA methylation patterns between high and low responders to a weight loss intervention in overweight or obese adolescents: the EVASYON study. FASEB J 2013; 27:2504-2512
38. Lee YS. The role of leptin-melanocortin system and human weight regulation: lessons from experiments of nature. Ann Acad Med 2009; 38:34-44.
39. Mountjoy KG, Mortrud MT, Low MJ, et al. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 1994; 8:1298-1308.
40. Mountjoy KG, Wild JM. Melanocortin-4 receptor mRNA expression in the developing autonomic and central nervous systems. Brain Res Dev Brain Res. 1998;107:309-314.
41. Huszar D, Lynch CA, Fairchild-Huntress V, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997; 88:131-141.
42. Vaisse C, Clement K, Durand E, et al. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 2000;106:253-262.
43. Farooqi IS, Keogh JM, Yeo GS, et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003;348:1085-1095.
44. Miraglia Del Giudice E, Cirillo G, Nigro V, et al.Low frequency of melanocortin-4 receptor (MC4R) mutations in a Mediterranean population with earlyonset obesity. Int J Obes Relat Metab Disord. 2002;26:647-651.
45. Jacobson P, Ukkola O, Rankinen T, et al. Melanocortin 4 receptor sequence variations are seldom a cause of human obesity: the Swedish Obese Subjects, the HERITAGE Family Study, and a Memphis cohort. J Clin Endocrinol Metab 2002; 87:4442-4446.
46. Hinney A, Hohmann S, Geller F, et al. Melanocortin-4 receptor gene: casecontrol study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity. J Clin Endocrinol Metab 2003; 88:4258-4267.
47. Ohshiro Y, Sanke T, Ueda K, et al. Molecular scanning for mutations in the melanocortin-4 receptor gene in obese/diabetic Japanese. Ann Hum Genet.1999;63:483-487.
48. Larsen LH, Echwald SM, Sorensen TI, et al. Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity. J Clin Endocrinol Metab 2005; 90:219-224.
49. Adams TD, Heath EM, LaMonte MJ, et al. The relationship between body mass index and per cent body fat in the severely obese. Diabetes Obes Metab.2007;9:498-505.
50. Rong R, Tao YX, Cheung BM, et al. Identification and functional characterization of three novel human melanocortin-4 receptor gene variants in an obese Chinese population. Clin Endocrinol (Oxf) 2006; 65:198-205.
51. Wang CL, Liang L, Wang HJ, et al. Several mutations in the melanocortin 4 receptor gene are associated with obesity in Chinese children and adolescents. J Endocrinol Invest 2006; 29:894-898.
52. Lee YS, Poh LK, Kek BL, Loke KY. Novel melanocortin 4 receptor gene mutations in severely obese children. Clin Endocrinol (Oxf) 2008; 68:529-535.
53. Hatoum IJ, Stylopoulos N, Vanhoose AM, et al. Melanocortin-4 receptor signaling is required for weight loss after gastric bypass surgery. J Clin Endocrinol Metab 2012; 97:E1023-1031.
54. Censani M, Conroy R, Deng L, et al. Weight loss after bariatric surgery in morbidly obese adolescents with MC4R mutations. Obesity (Silver Spring).2013
55. Valette M, Poitou C, Le Beyec J, et al. Melanocortin-4 receptor mutations and polymorphisms do not affect weight loss after bariatric surgery. PloS One. 2012;7:e48221.
56. Hinney A, Bettecken T, Tarnow P, et al. Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany. J Clin Endocrinol Metab 2006; 91:1761-1769.
57. Scrimshaw NS, Hussein MA, Murray E, et al. Protein requirements of man: variations in obligatory urinary and fecal nitrogen losses in young men. J Nutr.1972;102:1595-1604.
58. Xiang Z, Litherland SA, Sorensen NB, et al. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist. Biochemistry 2006; 45:7277-7288.
59. Stutzmann F, Vatin V, Cauchi S, et al. Nonsynonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene. Hum Mol Genet 2007; 16:1837-1844.
60. Young EH, Wareham NJ, Farooqi S, et al.The V103I polymorphism of the MC4R gene and obesity: population based studies and meta-analysis of 29 563 individuals. Int J Obes (Lond).2007;31:1437-1441.
61. Wang D, Ma J, Zhang S, et al. Association of the MC4R V103I polymorphism with obesity: a Chinese case-control study and meta-analysis in 55 195 individuals. Obesity (Silver Spring) 2010; 18:573-579.
62. Gantz I, Konda Y, Tashiro T, et al. Molecular cloning of a novel melanocortin receptor. J Biol Chem 1993; 268:8246-8250.
63. Roselli-Rehfuss L, Mountjoy KG, Robbins LS, et al. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci U S A 1993; 90: 8856-8860.
64. Chen AS, Marsh DJ, Trumbauer ME, et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass.Nat Genet.2000;26:97-102
65. Butler AA, Kesterson RA, Khong K, et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology.2000;141:3518-3521.
66. Lee YS, Poh LK, Kek BL, Loke KY. The role of melanocortin 3 receptor gene in childhood obesity. Diabetes 2007; 56:2622-2630.
67. Mencarelli M, Dubern B, Alili R, et al. Rare melanocortin-3 receptor mutations with in vitro functional consequences are associated with human obesity. Hum Mol Genet 2011; 20:392-399.
68. Calton MA, Ersoy BA, Zhang S, et al. Association of functionally significant Melanocortin-4 but not Melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study. Hum Mol Genet 2009;18:1140-1147.
69. Feng N, Young SF, Aguilera G, et al. Co-occurrence of two partially inactivating polymorphisms of MC3R is associated with pediatric-onset obesity. Diabetes 2005; 54:2663-2667.
70. Savastano DM, Tanofsky-Kraff M, Han JC, et al. Energy intake and energy expenditure among children with polymorphisms of the melanocortin-3 receptor. Am J Clin Nutr 2009; 90:912-920.
71. Santoro N, Zhang CK, Zhao H, et al. Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents. Hepatology 2012; 55:781-789.
72. Santoro N, Feldstein AE, Enoksson E, et al. The association between hepatic fat content and liver injury in obese children and adolescents: effects of ethnicity, insulin resistance, and common gene variants. Diabetes Care 2013;36:1353-1360
73. Lin YC, Chang PF, Hu FC, et al. A common variant in the PNPLA3 gene is a risk factor for nonalcoholic fatty liver disease in obese Taiwanese children. J Pediatr 2011; 158:740-744.
74. Lin YC, Chang PF, Chang MH, Ni YH. A common variant in the peroxisome proliferator-activated receptor-gamma coactivator-1alpha gene is associated with nonalcoholic fatty liver disease in obese children. Am J Clin Nutr 2013;97:326-331
75. Ooi SQ, Chan RM, Poh LK, et al. Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children. Pediatr Obes 2013. [Epub ahead of print] Study about the discovery of susceptibility genetic variants to adverse cardiometabolic parameters in obese children.